DPHARMA
Quarterly rpt on consolidated results for the financial period ended 31/3/2009
CCM DUOPHARMA BIOTECH BERHAD |
Financial Year End | 31/12/2009 |
Quarter | 1 |
Quarterly report for the financial period ended | 31/03/2009 |
The figures | have not been audited |
SUMMARY OF KEY FINANCIAL INFORMATION31/03/2009 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
31/03/2009 | 31/03/2008 | 31/03/2009 | 31/03/2008 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
1 | Revenue | 27,665 | 27,473 | 27,665 | 27,473 |
2 | Profit/(loss) before tax | 9,369 | 9,846 | 9,369 | 9,846 |
3 | Profit/(loss) for the period | 6,978 | 7,312 | 6,978 | 7,312 |
4 | Profit/(loss) attributable to ordinary equity holders of the parent | 6,978 | 7,312 | 6,978 | 7,312 |
5 | Basic earnings/(loss) per share (sen) | 5.03 | 5.27 | 5.03 | 5.27 |
6 | Proposed/Declared dividend per share (sen) | 0.00 | 0.00 | 0.00 | 0.00 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
7 | Net assets per share attributable to ordinary equity holders of the parent (RM) | 0.9900 | 0.9400 |
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
Announcement Info
Company Name | CCM DUOPHARMA BIOTECH BERHAD |
Stock Name | CCMDBIO |
Date Announced | 26 May 2009 |
Category | Financial Results |
Reference No | CD-090525-38925 |